The NM_000407.5(GP1BB):c.338A>G (p.Tyr113Cys) is a rare missense variant with a Grpmax Filtering allele frequency in gnomAD v4.1 is 0.00004600 (based on 4/29100 alleles in the East Asian population), which is lower than the ClinGen PD VCEP threshold (<0.00006517; PM2_Supporting). The computational predictor REVEL gives a score of 0.748, which is above the ClinGen PD VCEP threshold of >0.644 and predicts a damaging effect on function (PP3). Plasmids encoding GPIb, GPIb and GPIX were transiently transfected into 293T cells, and this variant suppressed the expression of GPIb/IX complexes (PMID: 11816714; PS3_supporting). This variant has been reported in one homozygous BSS patient (PMID: 11816714; PM3_supporting) and one compound heterozygous BSS patient (PMID: 24051937) with in trans variant Arg82Cys (classified VUS by the PD VCEP). At least one patient (PMID: 11816714) with this variant had aggregation absent for ristocetin and present for all other agonists and GPIb was detectable in reduced amounts on platelet surfaces by flow cytometry, which is highly specific for Bernard-Soulier syndrome (PP4). Additionally, the patient had excessive mucocutaneous bleeding and macrothrombocytopenia which are consistent with Bernard-Soulier syndrome. Seven individuals heterozygous for the variant are considered informative due to measurable, quantitative abnormalities relevant to the disease (i.e. significantly reduced platelet surface expression of GP1b, giant platelets, and macrothrombocytopenia) in PMIDs: 11816714 and 28064200 (PS4_moderate). Plus there was segregation of this variant in 5 additional informative heterozygous family members (PMID: 28064200 and PMID: 11816714; PP1). In summary this variant is classified as Likely Pathogenic using the ACMG criteria specified by the PD VCEP: PS4_Moderate, PS3_supporting, PM2_supporting, PM3_supporting, PP1, PP3, and PP4.